Immune defects in patients with chronic lymphocytic leukemia.
about
Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological MalignancyIdentification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia.CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases.Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemiaNCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantatioPrediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.Immunoglobulin replacement therapy in secondary hypogammaglobulinemiaAntibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals.Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia.Corticosteroid-responsive pulmonary toxicity associated with fludarabine monophosphate: a case report.The immunodeficiency of chronic lymphocytic leukaemia.Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.Optimal management of skin cancer in immunosuppressed patients.Shifting paradigms in the treatment of chronic lymphocytic leukemia.The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.Rapid progression of pulmonary blastomycosis in an untreated patient of chronic lymphocytic leukemia.Mannose-binding lectin 2 (MBL2) gene polymorphisms do not influence frequency of infections in chronic lymphocytic leukemia patients.Femoral Pseudoaneurysm as a Complication of Infective EndocarditisImmune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy.Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.Outcomes in critically ill chronic lymphocytic leukemia patients.Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: analysis of risk factors.Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target DrugsImmunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemiaKaposi's sarcoma in an HIV-negative chronic lymphocytic leukemia patient without immunosuppressive therapy: A case report
P2860
Q28080304-DFE31E1D-00C2-404B-A759-B5BAFDA5D145Q33387390-60116F2A-FB53-49E0-A3E1-452528215119Q33829089-A867CCAC-6CC5-40F2-8D62-8F4BD8D9E738Q33903452-860669B3-3486-45CF-B2D7-F9EF15D56545Q34011555-D30CF326-5CC1-42F8-8064-CB5956EDDDC9Q34202277-422970B4-E21D-4DCC-8C25-3ADE787A48F7Q34586203-D725550A-9885-43E5-BB87-4EEC3A5A71A1Q34652046-37985DF3-6366-4218-A3EE-22A41F564908Q34704085-0F2A53BD-29D7-4D29-9963-324CF4379D04Q35001579-16172831-3C67-4709-9847-C6D761E2C3D8Q36338377-A314683F-1CB8-4122-8035-41E75ED6AED1Q36637647-EB1FA812-61E1-484F-927B-BF9D797CA234Q37193886-EE5C9A6C-494D-406A-B63E-1F1B3A7F8A1EQ37255621-EE30B3C2-E529-49D7-A26C-0772B5000312Q37621400-C4297F89-A41D-44A8-B269-9BEF526AEE8DQ37971736-7D9EBF93-11C6-482D-8B00-9ECE1C144240Q38107449-F204B075-B425-4489-97CA-A342E2A23240Q38228585-266A8E35-520A-45C4-A250-288EDA90DEB0Q38357127-880E5317-67CD-4A50-8FB3-54F295BCE10BQ38473746-835D65D7-BFFF-4697-A651-E67704F871CFQ38795217-D6CA20BB-F405-4DD9-BCA7-AF2A41F4D580Q39074223-660B3072-1A8A-4B9C-92C4-5B57DC546331Q39232521-A0C45FC1-314E-47E2-88CD-22D321F4276BQ39360846-C6C947AD-656D-4AD1-A9C9-A920A97854FBQ39704505-E3D56B40-A3C9-4BEC-AD85-53BF82865106Q42274119-990BAC02-F420-46EB-BC9F-17DCCF132BBEQ44413722-45EF3EFE-59BB-40CA-91CA-396896A0F7FCQ45901753-E2706AB2-FC65-4CDB-84E0-70AAB7592F11Q47552836-F5B869DA-27B6-4DA0-B47A-A406289F9E04Q48120395-C9D5B8F8-F5DF-4FC9-883F-FDFF67D39885Q55119191-EC8F7A18-E868-4304-9967-A2BFEA7FEF85Q58701117-98C8B16A-991C-4699-AC43-B48890E5EC10Q58744741-2A2321CC-EFF4-4906-825D-172F8361E586Q58756174-CD55DB15-F350-402B-8D9A-3BE07AD0BE71
P2860
Immune defects in patients with chronic lymphocytic leukemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immune defects in patients with chronic lymphocytic leukemia.
@ast
Immune defects in patients with chronic lymphocytic leukemia.
@en
type
label
Immune defects in patients with chronic lymphocytic leukemia.
@ast
Immune defects in patients with chronic lymphocytic leukemia.
@en
prefLabel
Immune defects in patients with chronic lymphocytic leukemia.
@ast
Immune defects in patients with chronic lymphocytic leukemia.
@en
P2860
P1476
Immune defects in patients with chronic lymphocytic leukemia.
@en
P2860
P2888
P304
P356
10.1007/S00262-005-0015-8
P577
2005-07-16T00:00:00Z